Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Users Online: 23128

 

Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Advertise Contacts Login 
     

    Article Cited by others

CASE REPORT

Coexistence of JAK2 and BCR-ABL mutation in patient with myeloproliferative neoplasm

Hassan Abdulaziz, Dogara Livingstone Gayus, Babadoko Ahmadu Aliyu, Awwalu Sani, Mamman Aisha Indo

Year : 2015| Volume: 56| Issue : 1 | Page no: 74-76

   This article has been cited by
 
1 From primary myelofibrosis to chronic myeloid leukemia, BCR::ABL1+ B-Lymphoblastic leukemia, and back to primary myelofibrosis: An illustration of dynamic clonal evolution
Devin Wang, Wataru Kamata, Fengxi Ye, M. James You
eJHaem. 2024;
[Pubmed]  [Google Scholar] [DOI]
2 Cytological Diagnosis of Classic Myeloproliferative Neoplasms at the Age of Molecular Biology
Sophie Combaluzier, Julie Quessada, Norman Abbou, Robin Arcani, Antoine Tichadou, Jean Gabert, Régis Costello, Marie Loosveld, Geoffroy Venton, Yaël Berda-Haddad
Cells. 2023; 12(6): 946
[Pubmed]  [Google Scholar] [DOI]
3 Is very high platelet count always associated with essential thrombocythemia? An unusual presentation in a child
Elif Habibe Aktekin, Nalan Yazici, Ilknur Kozanoglu, Ayse Erbay
Laboratory Medicine. 2023;
[Pubmed]  [Google Scholar] [DOI]
4 Case report of a patient with chronic myeloid leukemia, BCR::ABL1 positive presented with isolated thrombocytosis and an uncommon JAK2 alteration detected in peripheral blood
Austin L. Gray, Edina A. Wappler-Guzzetta, Jun Wang, Huynh Le Cao, Yan Liu
Journal of Hematopathology. 2022;
[Pubmed]  [Google Scholar] [DOI]
5 JAK2-V617F is a negative regulation factor of SHIP1 protein and thus influences the AKT signaling pathway in patients with Myeloproliferative Neoplasm (MPN)
Madeleine Glück, Lina Dally, Manfred Jücker, Patrick Ehm
The International Journal of Biochemistry & Cell Biology. 2022; : 106229
[Pubmed]  [Google Scholar] [DOI]
6 Co-existence of BCR-ABL and JAK2V617F mutation in resistant chronic myeloid leukemia in the imatinib era: Is there a correlation?
Rim Frikha,Fatma Turki,Olfa Kassar,Moez Elloumi,Hassen Kamoun
Journal of Oncology Pharmacy Practice. 2021; 27(7): 1784
[Pubmed]  [Google Scholar] [DOI]
7 Generalized granuloma annulare associated with essential thrombocythemia
Sai P. Polineni,Steven Lawyer
Clinical Case Reports. 2020;
[Pubmed]  [Google Scholar] [DOI]
8 Coexistence of breakpoint cluster region-Abelson1 rearrangement and Janus kinase 2 V617F mutation in chronic myeloid leukemia: A case report
Xue-Bing Shi,Ji-Fa Jiang,Feng-Xiang Jin,Wei Cheng
World Journal of Clinical Cases. 2019; 7(9): 1087
[Pubmed]  [Google Scholar] [DOI]
9 The co-occurrence of driver mutations in chronic myeloproliferative neoplasms
Prajwal Boddu,Dai Chihara,Lucia Masarova,Naveen Pemmaraju,Keyur P. Patel,Srdan Verstovsek
Annals of Hematology. 2018;
[Pubmed]  [Google Scholar] [DOI]
10 Clinical characteristics and whole exome/transcriptome sequencing of coexisting chronic myeloid leukemia and myelofibrosis
Malathi Kandarpa,Yi-Mi Wu,Dan Robinson,Patrick William Burke,Arul M. Chinnaiyan,Moshe Talpaz
American Journal of Hematology. 2017;
[Pubmed]  [Google Scholar] [DOI]
11 Mutations in myeloproliferative neoplasms – their significance and clinical use
Fiorella Schischlik,Robert Kralovics
Expert Review of Hematology. 2017; : 1
[Pubmed]  [Google Scholar] [DOI]
12 MYC Deregulation in Primary Human Cancers
Manpreet Kalkat,Jason De Melo,Katherine Hickman,Corey Lourenco,Cornelia Redel,Diana Resetca,Aaliya Tamachi,William Tu,Linda Penn
Genes. 2017; 8(6): 151
[Pubmed]  [Google Scholar] [DOI]
13 ASXL1andJAK2V617Fgene mutation screening in Iranian patients with chronic myeloid leukemia
Amir VALIKHANI,Behzad POOPAK,Shirin FERDOWSI,Ghasem AZIZI TABESH,Seyed H GHAFFARI,Ehsan SARAF KAZERUONI,Negar REZAEI,Alireza FARSHCHI,Naser AMIRIZADEH
Asia-Pacific Journal of Clinical Oncology. 2016;
[Pubmed]  [Google Scholar] [DOI]
14 Laboratory Investigation of Myeloproliferative Neoplasms (MPNs)
Lambert Busque,Anna Porwit,Radmila Day,Harold J. Olney,Brian Leber,Vincent Éthier,Shireen Sirhan,Linda Foltz,Jaroslav Prchal,Suzanne Kamel-Reid,Aly Karsan,Vikas Gupta
American Journal of Clinical Pathology. 2016; 146(4): 408
[Pubmed]  [Google Scholar] [DOI]

 

Read this article